Senior haematologists have called NHS England to reverse restrictions on using ibrutinib to treat relapsed chronic lymphocytic leukaemia.
NHS England has been accused of over-riding guidance from the National Institute for Health and Care Excellen...
6 years ago
The outcome of a new study may help predict how patients with advanced chronic lymphocytic leukaemia (CLL) will respond to chimeric antigen receptor (CAR) T cell therapy, it has been announced.
A team from University of Pennsylvania Perelman Scho...
6 years ago
